Skyepharma Plc (SKYEY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 12-1999 | 12-1998 | 12-1997 | 12-1996 | |
| Sales | 36,280 | 28,670 | 18,120 | 22,950 | 17,420 |
| Cost of Goods | 23,300 | 24,010 | 17,630 | 16,910 | 13,480 |
| Gross Profit | 12,980 | 4,660 | 480 | 6,040 | 3,930 |
| Operating Expenses | 44,170 | 36,320 | 27,730 | 25,860 | 18,600 |
| Operating Income | -31,190 | -31,660 | -27,240 | -19,820 | -14,660 |
| Interest Expense | 0 | 2,240 | 11,600 | 8,380 | 4,620 |
| Other Income | 1,790 | 2,740 | 2,330 | -1,190 | -630 |
| Pre-tax Income | -29,400 | -31,160 | -36,510 | -29,390 | -19,910 |
| Income Tax | 6 | 210 | 140 | 100 | 110 |
| Net Income Continuous | -29,406 | -31,370 | -36,650 | -29,490 | -23,070 |
| Net Income | $-29,410 | $-31,380 | $-36,650 | $-29,490 | $-23,080 |
| EPS Basic Total Ops | -5.64 | -6.78 | N/A | N/A | N/A |
| EPS Basic Continuous Ops | -5.64 | -6.77 | N/A | N/A | N/A |
| EBITDA(a) | $-31,190 | $-31,660 | $-27,240 | $-19,820 | $-14,660 |